Celltrion
068270.KS
#754
Rank
NZ$44.95 B
Marketcap
$217.06
Share price
0.72%
Change (1 day)
5.84%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: NZ$44.95 Billion

As of November 2024 Celltrion has a market cap of NZ$44.95 Billion. This makes Celltrion the world's 754th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$44.95 B-15.08%
2023NZ$52.94 B85.4%
2022NZ$28.55 B-15.88%
2021NZ$33.94 B-45.68%
2020NZ$62.49 B111.38%
2019NZ$29.56 B-20.15%
2018NZ$37.02 B2.16%
2017NZ$36.24 B130.94%
2016NZ$15.69 B32.9%
2015NZ$11.80 B155.48%
2014NZ$4.62 B6.48%
2013NZ$4.34 B-17.82%
2012NZ$5.28 B12.9%
2011NZ$4.67 B4.7%
2010NZ$4.46 B146.11%
2009NZ$1.81 B30.64%
2008NZ$1.38 B5598.62%
2007NZ$24.38 M

End of Day market cap according to different sources

On Nov 9th, 2024 the market cap of Celltrion was reported to be:

NZ$44.99 Billion
by Yahoo Finance info icon info icon
NZ$44.95 Billion
by CompaniesMarketCap info icon info icon